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Abstract
We report the case of a 56-year-old white man who presented at the Emergency Department for
evaluation of dark-red urine. Rapid development of acute renal failure and haemolytic anaemia initially
elicited the hypothesis of a haemolytic-uremic syndrome. A previous exposure to a gas mixture
containing arsenic and copper was later recognized as the probable aetiology while other differential
diagnoses were excluded. Chelating treatment was promptly initiated before laboratorial
confirmation of arsenic and copper poisoning. Renal and haematological recovery was gradually
observed and the patient survived with no sequelae.
Introduction
Haemolytic anaemia may be secondary to a wide range
of causes either inherited or acquired. The former
include disturbances affecting haemoglobin, the membrane-
cytoskeleton complex and enzyme deficiency states. The latter
include mechanical destruction, drugs, infections, auto-
immune disorders or toxic agents.
Toxic agents are an uncommon cause of haemolysis,
which may develop even in people without metabolic
abnormalities. Many chemicals, due to their oxidative
potential, canlead to haemolysis. Other agentsact through
non oxidative, largely unknown mechanisms, such as
arsine, stibine, copper, and lead [1].
Acute poisoning with heavy metals is a rare cause for
evaluation in the Emergency Department. Its identifi-
cation may prove difficult particularly in unconscious
patients with no obvious history. A low-level exposure
may even be disregarded by the patient himself. This may
challenge the initial approach for a problem which can
result in a lethal outcome.
Case presentation
A 56-year-old white man was referred to our Emergency
Department (ED) for evaluation of dark-red urine.
The patient complained of a general feeling of sickness,
diffuse muscle pain, transient episodes of diaphoresis and
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vomiting for the past 24 hours. The appearance of dark-red
coloured urine,resembling blood, motivated his search for
medical care.
He denied abdominal pain or any recent traumatic event.
His past medical history was positive for chronic gastritis.
He had no past of nephrolithiasis or haematological
disorders. He was taking a protein-pump inhibitor and
denied use of any over-the-counter substances. He was an
occasional pipe smoker and had no history of alcohol
abuse or illicit drug consumption. His family history was
unremarkable.
On physical examination, his blood pressure was
132/78 mmHg, with a heart rate of 78 beats per minute, a
tympanic temperature of 36.8ºC, and a respiratory rate of
18 breaths per minute. There were no signs of dehydration.
He had no costovertebral angle tenderness. He had no
chronic liver disease stigmata. Further examination, includ-
ing neurological evaluation, was unremarkable. Initial
laboratory data included: Hb = 13.8 g/dL, MCV = 101.4 fL,
MCHC = 32.3 g/dL, RDW = 79.8 fl, WBC = 18.01 × 10
9/L,
P L T = 2 0 9×1 0
9/L; CRP = 8.5 mg/L, Cr = 1.55 mg/dL,
Urea = 80 mg/dL. Urinalysis revealed proteinuria (3+),
leukocyturia (80 cells/HPF), numerous renal tubular
epithelial cells, no erythrocyturia, and absent nitrites or
urobilinogen. Urinary tract ultrasound excluded signs of
lithiasis or obstruction and revealed bilateral renal paren-
chyma hyperechogenicity and slight perirenal oedema at
the right kidney; bladder wall visualization did not show
suspicious lesions and the prostate was normal.
He was admitted to the Urology Department for a
suspected urinary tract infection. A few hours later his
condition deteriorated. He developed jaundice, fever
(38.6°C), diarrhoea and mental confusion. His blood
panel revealed a normocytic normochromic anaemia with
anysocytosis (Hb = 8.0 g/dL, RDW = 83.2 fl), predomi-
nantly indirect hyperbilirrubinemia (TB = 5.82 mg/dL,
DB = 0.51 mg/dL), high LDH (4415 U/L), elevation of
inflammatory markers (WBC = 20.85 × 10
9/L, CRP =
108 mg/L) and worsening renal dysfunction (Cr = 3.59
mg/dL, Urea = 188 mg/dL) (Table 1).
He was transferred to the Intermediate Care Unit of the
Internal Medicine Department. Additional exams included
an ECG with normal sinus rhythm and normal QTc
interval (416 ms), a normal chest X-ray, a blood smear
with rare schizocytes, negative direct and indirect Coombs
tests and a fractional excretion of sodium of 3.49%.
These data pointed to a haemolytic cause for the rapidly
worsening anaemia (Table 1) and acute renal failure in
this context.
The association of acute renal failure and haemolytic
anaemia elicited the hypothesis of a haemolytic-uremic
syndrome. Considering other causes for a haemolytic
physiopathology which could not be immediately
excluded and the severity of the clinical condition of the
patient, plasmapheresis with fresh frozen plasma was
initiated and RBC transfused as needed.
Clinical history was revisited. The patient owned a factory
of zippers where chemical compounds were frequently
used in plating techniques. At this time the patient recalled
accidental inhalation of a possible toxic gas nearly
32 hours before, while performing a new plating process
wearing no protection. The gas resulted from the mixture
of a so-called “tin’s oxidant” with a metal alloy. This
exposure lasted no longer than 5 minutes and nearly
4 hours later he remembered feeling “sick”. Detailed
Table 1. In-hospital laboratorial course
Day 1 Day 1* Day 2 Day 3 Day 5 Day 6 Day 8 Day 10 Day 18
Hb, g/dL 13.8 11.5 8.0 9.4 8.7 7.9 9.3 9.9 10
WBC × 10
9/L 18.01 18.44 20.85 10.56 8.71 8.64 12.39 11.82 12.74
PLT × 10
9/L 209 167 141 69 89 89 124 250 299
CRP, mg/L 8.5 25.4 108.7 52 40.9 28.8 85.5 104 87.9
AST, U/L 112 121 207 57 34 35
ALT, U/L 33 36 193 156 91 31
gGT, U/L 18 19 27
ALP, U/L 71 62 43
TB, mg/dL 2.06 5.82 6.16 0.94 1.02 0.66 0.63
DB, mg/dL 0.43 0.51 0.48 0.23 0.72 0.15 0.14
LDH, U/L 4115 1430 997 659 549 289
Urea, mg/dL 80 135 188 182 144 112 70 65 59
Cr, mg/dL 1.55 2.56 3.59 4.96 4.43 4.34 3.45 3.86 2.79
Exposure to a gas mixture containing arsenic and copper occurred nearly 32 hours before initial medical evaluation. One session of plasmapheresis was
performed at in-hospital day 2. Penicillamine was administrated from day 4 to 7, followed by dimercaprol during 10 days. Transfusion with 1 pack of red
blood cells was performed at day 2. Haemolytic anaemia, renal dysfunction and hepatotoxicity recovered gradually after chelation therapy.
* Laboratorial results at approximately 12 hours of admission.
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ately requested.
At day 3, nearly 90 hours after the accidental exposure, the
composition of the toxic substance was known. “Tin’s
oxidant”, as the patient named it, included 40-45% of
chlorhydric acid (HCl), 1.2-1.4% of copper sulphate
(CuSO4), and 5-6% of arsenic trioxide (As2O3). Plasma-
pheresis was stopped at this time.
Blood and 24-hour urine samples were sent to the
laboratory for measurement of arsenic and copper levels.
Chelation treatment was initiated with Penicillamin
(1800mg/day per os), before laboratorial confirmation,
in order to address both copper and arsenic intoxication.
Initial therapy with intramuscular Dimercaprol was
postponed due to thrombocytopenia.
The patient completed 3 days of Penicillamin, followed by
the administration of intramuscular Dimercaprol 200 mg
at the following regime: 4-hourly in the first 6 days, then
6-hourly at day 7 and 8, and 12-hourly at day 9 and 10.
Simultaneously, forced alkalinisation was performed, with
fluid therapy as necessary.
Quantitative measurements were available at in-hospital
day 7 and confirmed high levels of arsenic and copper in
urine and blood (Table 2). Further measurements
demonstrated a progressive decline under the expected
chelation reaction (Figure 1). In repeated blood gas
analysis there was no methaemoglobin, a possible
consequence of copper intoxication.
During in-hospital stay, patient’s symptoms gradually
vanished and recovery of haematological, renal and liver
disturbances was observed. He did not present any
neurological or respiratory abnormalities. Syalorrhea and
inflammatory signs at intramuscular injection sites devel-
oped as a consequence of dimercaprol treatment. After
13 days of chelation he was discharged and referred for
follow-up appointments at the Internal Medicine and
Nephrology Outpatient Clinic.
One month later he remained asymptomatic. Physical
examination was unremarkable. Six months later his
haemoglobin level and renal function were normal
(Hb = 14.8 g/dL; MCV = 89.1 fL; MCHC = 34.1 g/dL;
Cr = 1.02 mg/dL, Urea = 46 mg/dL). The patient was
discharged.
Discussion
Arsenic is one the four most hazardous toxicants, along
with cadmium, lead, and mercury. Metal poisoning can
result from exposure to inhaled dusts, fumes or vapours.
Another possible route comes from ingestion of contami-
nated food, drinks or by hand-to-mouth exposure [2-4].
This patient presented with many of the classical clinical
findings attributed to arsenic acute intoxication. Initial
unspecific features of acute gastrointestinal findings may
be underappreciated, particularly if a recent exposure is
not known. Acute toxicity with arsenic manifests within
hours as nausea, vomiting, diarrhea, abdominal pain.
Severe poisoning may result in multi-organic failure,
delirium, seizures, coma, and ultimately death. If the
patient survives, bone marrow suppression, peripheral
neuropathy and skin lesions may develop [2-4].
Haemolytic anemia secondary to acute intoxication with
arsenic is a well-recognized effect [2-4]. Arsenic-related
haemolysis may also be a consequence of chronic
intoxication [5].
The gaseous state is one the most toxic forms of arsenic [6].
Cases of intoxication with arsine gas have been published
mostly as a result of accidental work-related exposures [6-9].
Table 2. Arsenic and copper blood and urine concentration 90 hours after
exposure (available at in-hospital day 7)
Results (µg/L) Normal values
Arsenic
24h urine 445 <100 µg/L
Blood 297 <70 µg/L
Copper
24h urine 137.9 15-60 µg/L
Blood 745 0.7-1.5 µg/L
Figure 1. Plotted concentrations of arsenic and copper in
blood and urine samples under chelation therapy. Chelating
therapy was preceded, three days before, by one session of
plasmapheresis. Penicillamine (Pen) was administrated
between days 4 and 7, followed by dimercaprol from days 8 to
18. Normal values: arsenic (24 h urine) <100 µg/L; arsenic
(blood) <70 µg/L; copper (24 h urine) = 15-60 µg/L; copper
(blood) = 0.7-1.5 µg/L.
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symptoms, persons exposed to hazardous levels may be
u n a w a r eo fi t sp r e s e n c e .I nc o n t r a s tw i t hr e p o r t e dc a s e s
following arsenic poisoning [8,10-17], our patient did not
develop respiratory failure.
Additionally, direct heart toxicity may result in distur-
bances of the electrical conduction system [2-4,15]. One
report described an early manifestation of torsade de pointes
after acute arsenic poisoning [18].
We can only retrospectively speculate about the initial
exposure dosage, which possibly was not high enough to
implicate direct respiratory or cardiac damage.
Treatment should be promptly initiated under high
suspicion of a recent intoxication. Primary treatment in
acute arsenic poisoning involves rapid decontamination
and early initiation of chelation therapy with agents such
as dimercaprol (British Anti-Lewsite, BAL), edentate
(EDTA), succimer (DMSA, dimercaptosuccinic acid)
and penicillamine. No specific antidote is available and
there are no controlled trials regarding different thera-
peutic strategies [2-4].
A recent case report has suggested plasma exchange as an
effective early treatment intervention for acute arsenic
poisoning [19]. In our case, plasmapheresis was per-
formed regarding the hypothesis of a haemolytic-uremic
syndrome, before any toxicodrome was suspected.
However, it may have contributed for the benign clinical
course since chelating treatment was only initiated nearly
100 hours after exposure.
In this case, it is not possible to separate the haemolytic
effect of copper from the arsenic one, since copper
intoxication may also cause haemolysis [20]. Methaemo-
globinemia is a frequent complication of copper poison-
ing which may require additional therapeutic strategies
[20]. Its absence in the presented case points against
a major contribution of this metal in patient’s clinical
course.
Conclusion
We report a rare case of haemolytic anaemia following
arsenic and copper acute intoxication. The unusual nature
of this aetiology and the delayed awareness of a possible
toxic exposure challenged the diagnosis.
Common consequences of arsenic poisoning are haemo-
lysis and renal failure.
Because of the severity of the clinical course, including
multi-organic failure and a high risk of death, therapeutic
strategies should presumptively be initiated without
formal laboratory confirmation. Evidence-based treatment
options are limited. Use of chelating agents, such as
dimercarprol, is recommended. Whether plasma exchange
should be a primary, an alternative or additional treatment
option remains unclear, although its early use may be an
effective treatment.
Abbreviations
ALP, alkaline phosphatase; Cr, creatinine; CRP, C-reactive
protein; DB, direct bilirubin; FENa, fractional excretion
of sodium; gGT, gamma glutamyl transpeptidase; Hb,
haemoglobin; HPF, high power field; LDH, lactate
dehydrogenase; MCHC, mean corpuscular haemoglobin
concentration; MCV, medium corpuscular volume; PLT,
platelet; RDW, red cell distribution width; TB, total
bilirubin; WBC, white blood cell.
Consent
Written informed consent was obtained from the patient
for publication of this case report. A copy of the written
consent is available for the review by the Editor-in-Chief
of this journal.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
NC gathered patient information, interpreted data, did
literature research, and wrote the first draft of the manu-
script. CC contributed majorly to preparation of the
manuscript and participated in management of plasma-
pheresis. JPA, JA and FF were responsible for the patient
during admission to Intermediate Care Unit, including
differential diagnosis, confirmation of final diagnosis and
treatment decisions. AA was responsible for the manage-
ment of the patient after discharge from the Intermediate
care Unit and followup at theoutpatient clinic.All authors
were involved in the clinical management of the patient,
and read and approved the final manuscript.
Acknowledgements
The authors are grateful to Prof. Dra. Maria de Lourdes
Bastos, Head of the Laboratory of Toxicology of the
Faculty of Pharmacy of the University of Porto, for the
collaboration in toxicological analyses.
References
1. Luzzato L: Hemolytic Anemias and Anemia Due to Acute
Bood Loss.I nHarrison’s Principle Internal Medicine. 17th edition.
Edited by Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL,
Jameson JL, Loscalzo J. New-York: McGraw-Hill; 2008, 652-662.
2. Arsenic exposure and poisoning. [http://www.uptodate.com]
3. Ratnaike RH: Acute and chronic arsenic toxicity. Postgrad Medl J
2003, 79:391-396.
4. Ford M: Arsenic. In Goldfrank's toxicologic emergencies. 7th edition.
Edited by Goldfrank LR, Flomenbaum NE, Lewin N, Howland MA,
Hoffman R, Nelson L. New York: McGraw-Hill; 2002, 1183-1195.
Page 4 of 5
(page number not for citation purposes)
Cases Journal 2009, 2:7768 http://casesjournal.com/casesjournal/article/view/77685. Lee JJ, Kim YK, Cho SH, Park KS, Chung IJ, Cho D, Ryang DW,
Kim HJ: Hemolytic anemia as a sequel of arsenic intoxication
following long-term ingestion of traditional Chinese medi-
cine. J Korean Med Sci 2004, 19:127-129.
6. Pakulska D, Czerczak S: Hazardous effects of arsine: a short
review. Int J Occup Med Environ Health 2006, 19:36-44.
7. Romeo L, Apostoli P, Kovacic M, Martini S, Brugnone F: Acute
arsine intoxication as a consequence of metal burnishing
operations. Am J Ind Med 1997, 32:211-216.
8. Barbee JY Jr, Prince TS: Acute respiratory distress syndrome in
a welder exposed to metal fumes. South Med J 1999, 92:510-512.
9. Sanz Guajardo A, Montero Garcia A, Moreno Heredia E, Sánchez
Sicilia L: Hemolysis and acute renal failure in collective arsine
poisoning (study of 5 cases). Rev Clin Esp 1970, 119:525-532.
10. Dueñas-Laita A, Pérez-Miranda M, González-López MA, Martín-
Escudero JC, Ruiz-Mambrilla M, Blanco-Varela J: Acute arsenic
poisoning - case report. Lancet 2005, 365:1982.
11. Isbister GK, Dawson AH: Arsenic trioxide poisoning: a descrip-
tion of two acute overdoses. Hum Exp Toxicol 2004, 23:359-364.
12. Lai MW, Boyer EW, Kleinman ME, Rodig NM, Ewald MB: Acute
arsenic poisoning in two siblings. Pediatrics 2005, 116:249-257.
13. Wang EE, Mahajan N, Wills B, Leikin J: Successful treatment of
potentially fatal heavy metal poisonings. J Emerg Med 2007,
32:289-294.
14. Vantroyen B, Heillier JF, Meulemans A, Michels A, Buchet JP,
Vanderschueren S, Haufroid V, Sabbe M: Survival after a lethal
dose of arsenic trioxide. J Toxicol Clin Toxicol 2004, 42:889-895.
15. Civantos DP, López Rodríguez A, Aguado-Borruey JM, Narvaez JA:
Fulminant malignant arrhythmia and multiorgan failure in
acute arsenic poisoning. Chest 1995, 108:1774-1775.
16. Greenberg C, Davies S, McGowan T, Schorer A, Drage C: Acute
respiratory failure following severe arsenic poisoning. Chest
1979, 76:596-598.
17. Bolliger CT, van Zijl P, Louw JA: Multiple organ failure with the
adult respiratory distress syndrome in homicidal arsenic
poisoning. Respiration 1992, 59:57-61.
18. Ortega Carnicer J, Ruiz Lorenzo F, Mañas García D, Ceres Alabau F:
Torsades de Pointes precoces y elevación sérica de la
troponina I debidas a intoxicación aguda por arsénico. Med
Intensiva 2006, 30:77-80.
19. Song Y, Wang D, Li H, Hao F, Ma J, Xia Y: Severe acute arsine
poisoning treated by plasma exchange. Clin Toxicol (Phila) 2007,
45:721-727.
20. Franchitto N, Gandia-Mailly P, Georges B, Galinier A, Telmon N,
Ducassé JL, Rougé D: Acute copper sulphate poisoning: a case
report and literature review. Resuscitation 2008, 78:92-96.
Do you have a case to share?
Submit your case report today
￿ Rapid peer review
￿ Fast publication
￿ PubMed indexing
￿ Inclusion in Cases Database
Any patient, any case, can teach us
something
www.casesnetwork.com
Page 5 of 5
(page number not for citation purposes)
Cases Journal 2009, 2:7768 http://casesjournal.com/casesjournal/article/view/7768